A Unique Robust Dual-Promoter-Driven and Dual-Reporter-Expressing SARS-CoV-2 Replicon: Construction and Characterization

The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2, SARS2) remains a great global health threat and demands identification of more effective and SARS2-targeted antiviral drugs, even with successful development of anti-SARS2 vaccines. Viral replicons have proven to be a rapid, safe, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ying, Li, Lu, Timani, Khalid A., He, Johnny J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143625/
https://www.ncbi.nlm.nih.gov/pubmed/35632716
http://dx.doi.org/10.3390/v14050974

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9143625/
https://www.ncbi.nlm.nih.gov/pubmed/35632716
http://dx.doi.org/10.3390/v14050974

Ejemplares similares